UK markets close in 3 hours 37 minutes

Royalty Pharma PLC (RPD.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
25.35+0.06 (+0.24%)
As of 01:05PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,238,561
2,354,554
2,237,215
2,289,463
2,122,353
-
Operating expenses
Research development
52,000
52,000
177,106
200,084
26,289
-
Selling general and administrative
221,705
249,748
227,303
182,826
181,715
-
Total operating expenses
1,299,157
862,404
1,314,323
858,748
461,901
-
Operating income or loss
939,404
1,492,150
922,892
1,430,715
1,660,452
-
Interest expense
184,469
187,187
187,961
166,142
157,059
-
Total other income/expenses net
368,785
322,834
-583,202
-76,907
170,182
-
Income before tax
1,186,726
1,700,088
230,064
1,241,201
1,701,954
-
Income tax expense
0
0
0
0
0
-
Income from continuing operations
1,186,726
1,700,088
230,064
1,241,201
1,701,954
-
Net income
798,857
1,134,834
42,832
619,728
975,040
-
Net income available to common shareholders
1,191,583
1,527,560
42,832
619,728
495,198
-
Basic EPS
0.39
-
0.10
1.49
2.51
6.63
Diluted EPS
0.39
-
0.10
1.49
2.51
6.63
Basic average shares
446,678
-
437,963
414,794
388,135
354,176
Diluted average shares
446,678
-
437,972
414,802
388,135
354,176